Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Vart

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Kidney International Reports|June 27, 2022
COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement TherapyPriya Vart, Kitty J Jager, Miha Arnol, et al.
Circulation|November 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and AlbuminuriaBrendon L Neuen, Hiddo J L Heerspink, Priya Vart, et al.
Journal of the American Society of Nephrology : JASN|November 7, 2025
Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled TrialJan-Stephan F Sanders, Silke E de Boer, Jip Jonker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2022
Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaborationPriya Vart, Raphaël Duivenvoorden, Casper F M Franssen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 14, 2022
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODAMarc H Hemmelder, Marlies Noordzij, Priya Vart, et al.
Trials|February 14, 2024
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trialThomas Bais, Esther Meijer, Bart J Kramers, et al.
Diabetologia|April 21, 2022
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trialSimke W Waijer, Priya Vart, David Z I Cherney, et al.
Clinical Kidney Journal|June 24, 2022
Association of obesity with 3-month mortality in kidney failure patients with COVID-19Ekamol Tantisattamo, Celine Imhof, Kitty J Jager, et al.
JAMA Cardiology|November 18, 2019
Effect of Face-to-Face vs Virtual Reality Training on Cardiopulmonary Resuscitation Quality: A Randomized Clinical TrialJoris Nas, Jos Thannhauser, Priya Vart, et al.
Kidney International Reports|May 2, 2022
Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic RegionsPriya Vart, Ricardo Correa-Rotter, Fan Fan Hou, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Kidney International Reports|June 27, 2022
COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement TherapyPriya Vart, Kitty J Jager, Miha Arnol, et al.
Circulation|November 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and AlbuminuriaBrendon L Neuen, Hiddo J L Heerspink, Priya Vart, et al.
Journal of the American Society of Nephrology : JASN|November 7, 2025
Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled TrialJan-Stephan F Sanders, Silke E de Boer, Jip Jonker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2022
Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaborationPriya Vart, Raphaël Duivenvoorden, Casper F M Franssen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 14, 2022
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODAMarc H Hemmelder, Marlies Noordzij, Priya Vart, et al.
Trials|February 14, 2024
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trialThomas Bais, Esther Meijer, Bart J Kramers, et al.
Diabetologia|April 21, 2022
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trialSimke W Waijer, Priya Vart, David Z I Cherney, et al.
Clinical Kidney Journal|June 24, 2022
Association of obesity with 3-month mortality in kidney failure patients with COVID-19Ekamol Tantisattamo, Celine Imhof, Kitty J Jager, et al.
JAMA Cardiology|November 18, 2019
Effect of Face-to-Face vs Virtual Reality Training on Cardiopulmonary Resuscitation Quality: A Randomized Clinical TrialJoris Nas, Jos Thannhauser, Priya Vart, et al.
Kidney International Reports|May 2, 2022
Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic RegionsPriya Vart, Ricardo Correa-Rotter, Fan Fan Hou, et al.
Pageof 13